Ravagalimab
Modify Date: 2024-04-11 13:18:20
Ravagalimab structure
|
Common Name | Ravagalimab | ||
|---|---|---|---|---|
| CAS Number | 2050816-56-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RavagalimabRavagalimab (ABBV-323) is a CD40 antagonist (EC50: 3.7 nM). Ravagalimab can be used for research of Crohn's disease[1]. |
| Name | Ravagalimab |
|---|
| Description | Ravagalimab (ABBV-323) is a CD40 antagonist (EC50: 3.7 nM). Ravagalimab can be used for research of Crohn's disease[1]. |
|---|---|
| Related Catalog | |
| Target |
CD40:3.7 nM (EC50) |
| In Vitro | Ravagalimab (0-100 nM，2 天) 抑制原代人 B 细胞上的 CD86 上调，EC50 为 0.6 nM[2]。 |
| References |
| No Any Chemical & Physical Properties |